Clinical Trials Browser

Phase 2 × Breast Neoplasms × Ascorbic Acid × Clear all

NCT02521077 2017-06-27

Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Fatigue